Federal Court Vacated $486,400 Patent Award
The ruling clarifies that private sales do not count as public disclosure, impacting how patent validity is judged.
Updated on Oct. 1, 2026 in Economic Indicators
Live Poll
Should private sales of an invention be considered public disclosures when defending patent rights?
On September 14, 2026, the U.S. Court of Appeals for the Federal Circuit vacated a $486,400 damages award in a patent dispute. The court determined that a private sale of an invention did not qualify as a public disclosure under the America Invents Act.
Why it matters
This decision changes how companies and individual inventors navigate the patent grace period by clarifying that confidential sales do not trigger public disclosure timelines. It ensures that private business activities do not inadvertently compromise an inventor's future intellectual property rights.
The court vacated a $486,400 jury damages award as part of its decision. The case centers on whether specific sales activity triggers patent eligibility, with the court still needing to resolve the infringement claims at trial.
The players
NCS Multistage Inc.
An energy technology company that creates specialized products for well construction and completions.
Nine Energy Service, Inc.
A provider of offshore and onshore completion services that was involved in this patent dispute.
U.S. Court of Appeals for the Federal Circuit
The federal court with exclusive jurisdiction over appeals involving patent law and trademark cases.
The details
The court held that NCS Multistage’s sale to a customer in July 2012 did not constitute a public disclosure because the item was delivered in sealed, confidential packaging. Because the invention was not made sufficiently available to the public, the court found the sale did not satisfy criteria for triggering the patent grace period established by the America Invents Act. Consequently, the court reversed two previous district court claim constructions and ordered a new trial.
Timeline
July 2012: NCS sold its product to a single customer.
2013: NCS filed its patent application.
September 14, 2026: Federal Circuit issued the decision in NCS Multistage.
Money Landscape
This ruling refines the interpretation of the America Invents Act by clarifying the threshold for public disclosure of inventions. It marks a departure from broader interpretations that might have otherwise penalized companies for confidential, early-stage business transactions.
Business owners and inventors should consult with a qualified patent attorney to ensure that any early-stage product sales or transfers are properly documented as confidential to preserve future intellectual property rights. This ruling reinforces the importance of maintaining strict confidentiality protocols during pre-patent commercial phases.
The takeaway
The court's decision highlights that keeping early product sales strictly confidential is essential for protecting potential patent rights. Business owners should review their confidentiality agreements and product delivery procedures to ensure they align with these disclosure standards.
Further reading
For more on how regulatory decisions impact business environments, visit the Economic Indicators section.
Live Poll
Should private sales of an invention be considered public disclosures when defending patent rights?
